Literature DB >> 2831854

Isolation and characterization of a human cytomegalovirus glycoprotein containing a high content of O-linked oligosaccharides.

B Kari1, R Gehrz.   

Abstract

Several disulfide linked glycoprotein complexes were extracted from human cytomegalovirus with a non-ionic detergent and separated by anion exchange high performance liquid chromatography (HPLC). One complex had a molecular weight of 93,000 and was classified as gCII-93. Another complex had a molecular weight greater than 200,000 and was classified as gCII-200. Both complexes immunoprecipitated with a monoclonal antibody (9E10). A third set of complexes (classified as gC-I) immunoprecipitated with another monoclonal antibody (41C2). Isolated complexes were reduced, alkylated, and individual glycoproteins separated by gel-filtration HPLC. Glycoproteins with molecular weights of 50-52,000 from gCII-93 and gCII-200 appeared to be the same glycoprotein since they could be immunoprecipitated by 9 E 10 and had identical peptide maps. The amino sugar content of these glycoproteins was compared to that of higher molecular weight glycoproteins obtained from gCII-200 and to a glycoprotein with a molecular weight of 93,000 (gp93 (I] from gCI. Glycoproteins with molecular weights of 50-52,000 from gCII-93 and gCII-200 contained similar amounts of galactosamine (GalN), glucosamine (GlcN) and sialic acid. However, they contained 2-3 times more GalN than any other glycoprotein from gCII-200 and 10 times more GalN than was detected in gp93 (I). All glycoproteins from gCII-93 or gCII-200 also contained more sialic acid when compared to gp93 (I). GalN in these glycoproteins was present in O-linked oligosaccharides. This was demonstrated by release of low molecular weight oligosaccharides from high molecular weight glycopeptides by mild base hydrolysis and the conversion of GalN to galactosaminitol. Thus, gp52(II) appears to have a unique phenotype marked by a high amount of O-linked oligosaccharides.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831854     DOI: 10.1007/BF01322167

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  30 in total

1.  Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.

Authors:  W J Britt; D Auger
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins.

Authors:  B Nowak; C Sullivan; P Sarnow; R Thomas; F Bricout; J C Nicolas; B Fleckenstein; A J Levine
Journal:  Virology       Date:  1984-01-30       Impact factor: 3.616

4.  Characterization of a herpes simplex virus type 2-specified glycoprotein with affinity for N-acetylgalactosamine-specific lectins and its identification as g92K or gG.

Authors:  S Olofsson; M Lundström; H Marsden; S Jeansson; A Vahlne
Journal:  J Gen Virol       Date:  1986-04       Impact factor: 3.891

5.  Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus.

Authors:  L Rasmussen; J Mullenax; R Nelson; T C Merigan
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

6.  Guinea-pig kidney beta-N-acetylgalactosaminyltransferase towards Tamm-Horsfall glycoprotein. Requirement of sialic acid in the acceptor for transferase activity.

Authors:  F Serafini-Cessi; F Dall'Olio
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

7.  Sialylated oligosaccharides O-glycosidically linked to glycoprotein C from herpes simplex virus type 1.

Authors:  F Dall'Olio; N Malagolini; V Speziali; G Campadelli-Fiume; F Serafini-Cessi
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

8.  Protein counterparts of human and simian cytomegaloviruses.

Authors:  W Gibson
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

9.  Mapping of the major glycoprotein gene of human cytomegalovirus.

Authors:  M Mach; U Utz; B Fleckenstein
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

10.  Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.

Authors:  M P Cranage; T Kouzarides; A T Bankier; S Satchwell; K Weston; P Tomlinson; B Barrell; H Hart; S E Bell; A C Minson
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  5 in total

1.  Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).

Authors:  M Mach; B Kropff; P Dal Monte; W Britt
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Analysis of human antibody responses to human cytomegalovirus envelope glycoproteins found in two families of disulfide linked glycoprotein complexes designated gC-I and gC-II.

Authors:  B Kari; R Gehrz
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Characterization of cytomegalovirus glycoproteins in a family of complexes designated gC-II with murine monoclonal antibodies.

Authors:  B Kari; R Goertz; R Gehrz
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope.

Authors:  B Kari; R Gehrz
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

5.  The human cytomegalovirus UL37 immediate-early regulatory protein is an integral membrane N-glycoprotein which traffics through the endoplasmic reticulum and Golgi apparatus.

Authors:  H O Al-Barazi; A M Colberg-Poley
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.